期刊文献+

心脏永久性起搏器植入患者门诊随访依从性分析 被引量:13

The Follow-up Study for Clinical Compliance in Patients With Permanent Pacemaker Implantation
下载PDF
导出
摘要 目的:分析心脏永久性起搏器植入患者门诊随访依从性的现状、影响因素及探讨提高随访依从性的方法。方法:回顾性分析2006-01至2013-01在我院住院植入心脏永久性起搏器的患者817例,对术后1年内的门诊随访情况进行依从性评判,并分析其影响因素。实际随访790例(96.70%),1年内未进行门诊随访者入电话随访组(n=350例),至少进行过1次门诊随访者入门诊随访组(n=440例)。结果:研究对象中,失访26例,失访率3.18%;非起搏器相关死亡1例,实际随访790例,实际随访率96.7%,其中门诊随访者440例(55.70%),电话随访者350例(44.30%)。两组在文化程度、医疗费用、居住地、对心律失常的了解、固定陪护人员方面的差异有统计学意义(P<0.05)。高中以上文化程度、医疗费用可报销、本地居住、对心律失常知识了解、有固定陪护人员的患者门诊随访率高。1年内总体并发症发生率1.8%,均未造成严重后果。随访时进行优化参数设置者占59.5%。结论:心脏永久性起搏器植入患者门诊随访率较低。影响因素较多,包括文化程度、医保制度、居住地、对心律失常的认知程度、有无陪护人员。 Objective: To analyze the current condition and inlfuencing factors for clinical compliance in patients with permanent pacemaker implantation and to improve the follow-up condition in relevant patients. Methods: A total of 817 patients with permanent pacemaker implantation in our hospital from 2006-01 to 2013-01 were retrospectively studied. The clinical compliance condition and inlfuencing factors were accessed for 1 year period. Results: There were 26/817 (3.18%) patients lost contact and 1 patient died. A total of 790 (96.7%) patients finished the followed-up study by 2 groups: Clinical visit group,n=440 (55.70%) and Telephone visit group,n=350 (44.30%). The education level, medical cost, residency, comprehension of arrhythmia and accompany personnel were different between 2 groups,P〈0.05. The patients were with high school education or above, reimbursed medical cost, local residency, comprehension of arrhythmia and accompany personnel had the higher clinical visit rate. The overall 1 year occurrence rate of complication was 1.8% without severe event. There were 59.5% of patients optimized the pacemaker parameters during clinical visit. Conclusion: The patients with permanent pacemaker implantation had the lower rate of clinical follow-up visit which should be improved in several issues.
出处 《中国循环杂志》 CSCD 北大核心 2014年第10期784-786,共3页 Chinese Circulation Journal
基金 全军医学科技青年培育项目计划(编号13QNP165)
关键词 起搏器 随访 依从性 Cardiac pacemaker Follow-up Compliance
  • 相关文献

参考文献9

二级参考文献29

  • 1杨运方,洪倩,储文革,汤静,张丽,程利民.家庭综合干预是改善高血压患者治疗依从性的有效措施[J].中国初级卫生保健,2005,19(4):43-44. 被引量:11
  • 2安利杰,武爱萍,杜艳英,巴建鹏,汪漫,齐艳红,张峥,袁彬.指示性与危险意识性健康教育对冠心病患者生活方式依从性的影响[J].中国实用护理杂志,2005,21(11):51-52. 被引量:21
  • 3王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 4叶晓青,林芳宇,陈维清.高血压病患者药物治疗依从性影响因素的研究[J].现代预防医学,2007,34(3):494-496. 被引量:33
  • 5Maisel WH. Pacemaker and ICD Generator Reliability Meta-analysis of Device Registries. JAMA ,2006,295:1929-1934.
  • 6Ribeiro AL, Rincon LG, Oliveira BG, et al. Enhancing longevity of pacemakers through reprogramming. Underutilization and cost-effectiveness. Arq Bras Cardiol,2001,76 :437-444.
  • 7Boriani G, Rusconi. Role of ventricular autocapture function in increasing longevity of DDDR pacemakers: a prospective study Europace ,2006,8 ( 3 ) :216-220.
  • 8Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions : analysis of Food and Drug Administration annum reports. JAMA ,2006,295 : 1901-1906.
  • 9Aydemir O, Ozmen E, Ktiey L, et al. Psychiatric morbidity and depressive symptomatology in patients with permanent pacemakers. PACE, 1997,20 : 1628-1832.
  • 10Kapa S, Hyberger L, Rea RF, et al. Complication risk with pulse gererator change:implications when reacting to a device advisory or recall. PACE ,2007,30:730-733.

共引文献126

同被引文献122

  • 1胡海波,蒋世良,徐仲英,赵世华,黄连军,吴文辉,刘延龄,王浩,王云.儿童膜周部室间隔缺损介入治疗的临床评价[J].中华儿科杂志,2004,42(11):808-812. 被引量:18
  • 2刘加林,梁传余,王力红,刘世喜.《华西医学》临床资料随访的现状与对策[J].华西医学,2005,20(1):7-8. 被引量:13
  • 3周炯,王荫华.六个常用的焦虑抑郁量表的相关因子分析[J].中华神经科杂志,2005,38(11):714-714. 被引量:119
  • 4Ruilope LM, Aldigier JC, Ponticelli C, et al. Safety of the combination of valsartan and benazepril in patients with chronic renal disease[J]. JHypertens, 2000,18( 1 ) :89.
  • 5Sleight P, Redon J, Verdecchia P, et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study[J]. J Hypertens, 2009,27(7) : 1 360.
  • 6Maschio G, Alberti D, Janin G, et aL Effect of the angio- tensin-converting-enzyme inhibitor benazepril on the pro- gression of chronic renal insufficiency[J]. New Engl J Med, 1996,334(15) :939.
  • 7Weber KT. Aldosterone in congestive heart failure[J]. New Engl J Med, 2001,345 (23) : 1 689.
  • 8Littlejohn TW, Majul CR, Olvera R, et al. Results of treat- ment with telmisartan-amlodipine in hypertensive patients [J]. J Clin Hypertens, 2009,11 (4) : 207-213.
  • 9Vancura V, Wichterle D, Melenovsky V, et al. Assessment of optim~ right ventricular pacing site using invasive measurement of left ventric- ular systolic and diastolic function [ J ]. Europace, 2013,15 ( 10 ) : 1482-1490.
  • 10Hoffmayer KS, Bhave PD, Marcus GM, et al. An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhyth- mias in patients with arrhythmogenic fight ventricular cardiomyopathy from idiopathic ventricular tachycardia [ J ]. Heart Rhythm, 2013,10 (4) :477-482.

引证文献13

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部